Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | CASP7 | P55210 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL340194 | 0.94 | ALDH1A1 (0.69) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL1705540 | 0.92 | ALDH1A1 (0.66) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| Acetic Acid SCHEMBL3776954 | 0.92 | ALDH1A1 (0.66) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL18338822 | 0.86 | ALDH1A1 (0.50) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL5718021 | 0.82 | POLB (0.62) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL6153958 | 0.82 | ALDH1A1 (0.51) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL4311418 | 0.81 | POLB (0.61) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL3389758 | 0.81 | ALDH1A1 (0.82) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL925084 | 0.78 | ALDH1A1 (0.92) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 | |
| SCHEMBL3368846 | 0.78 | POLB (0.69) | ALDH1A1CYP2C19CYP1A2POLBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10179103-B1 | Anti-cellulite cream | JAN MARINI SKIN RESEARCH (US) | 2019-01-15 | — | — | US | claimed |
| EP-4103144-B1 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-12629323-B2 | Cosmetic kit and its use as a make-up product | Oxygen Innovation SRL (IT) | 2026-05-19 | — | — | US | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4706780-A2 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20050004274-A1 | Gel compositions | HEALY LIN LU (US) | 2005-01-06 | — | — | US | disclosed |
| EP-0971686-B1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | BEIERSDORF AG (DE) | 2004-11-03 | — | — | EP | disclosed |
| WO-2004037221-A1 | METHOD FOR COSMETIC BODY TREATMENT TO ENHANCE THE SILHOUETTE AND TO DEVELOP THE FEMALE BUST, AND DOUBLE-ACTING COSMETIC COMPOSITION THEREFOR | INSTITUT JEANNE PIAUBERT (FR) | 2004-05-06 | — | — | WO | disclosed |
| EP-1256336-A2 | Two-phase gel composition | Penreco (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020055562-A1 | Gel compositions | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2002-05-09 | — | — | US | disclosed |
| US-20020025303-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | BOOTS COMPANY, THE PLC (GB) | 2002-02-28 | — | — | US | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
| EP-0971686-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | The Boots Company PLC (GB) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998044904-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF METHYLATED SILANOL AND A DERIVATIVE OF HYDROLYSED PLANT PROTEIN | THE BOOTS COMPANY PLC (GB) | 1998-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629323-B2 | Cosmetic kit and its use as a make-up product | KCNN1, LAGE3, CACNA2D1 | ALDH1A1 1686/4885CYP2C19 4614/4885CYP1A2 4840/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | ALDH1A1 156/4885CYP2C19 4225/4885CYP1A2 3874/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | ALDH1A1 705/4885CYP2C19 743/4885CYP1A2 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.